bupropion hydrochloride

Generic: bupropion hydrochloride

Labeler: sun pharmaceutical industries, inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name bupropion hydrochloride
Generic Name bupropion hydrochloride
Labeler sun pharmaceutical industries, inc.
Dosage Form TABLET, EXTENDED RELEASE
Routes
ORAL
Active Ingredients

bupropion hydrochloride 150 mg/1

Manufacturer
Sun Pharmaceutical Industries, Inc.

Identifiers & Regulatory

Product NDC 63304-723
Product ID 63304-723_45fe751e-5918-745c-e063-6394a90a5c56
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA200216
Listing Expiration 2026-12-31
Marketing Start 2020-12-09

Pharmacologic Class

Classes
aminoketone [epc] dopamine uptake inhibitors [moa] increased dopamine activity [pe] increased norepinephrine activity [pe] norepinephrine uptake inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 63304723
Hyphenated Format 63304-723

Supplemental Identifiers

RxCUI
993541
UPC
0363304723304
UNII
ZG7E5POY8O

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name bupropion hydrochloride (source: ndc)
Generic Name bupropion hydrochloride (source: ndc)
Application Number ANDA200216 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 150 mg/1
source: ndc
Packaging
  • 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (63304-723-05)
  • 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (63304-723-30)
  • 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (63304-723-90)
source: ndc

Packages (3)

63304-723-05 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (63304-723-05) 63304-723-30 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (63304-723-30) 63304-723-90 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (63304-723-90)

Ingredients (1)

bupropion hydrochloride (150 mg/1)

Linked Drug Pages (1)

Bupropion hydrochloride ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "45fe751e-5918-745c-e063-6394a90a5c56", "openfda": {"upc": ["0363304723304"], "unii": ["ZG7E5POY8O"], "rxcui": ["993541"], "spl_set_id": ["195b9970-0bc6-4f48-9450-a91292ad4618"], "manufacturer_name": ["Sun Pharmaceutical Industries, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "500 TABLET, EXTENDED RELEASE in 1 BOTTLE (63304-723-05)", "package_ndc": "63304-723-05", "marketing_start_date": "20201209"}, {"sample": false, "description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE (63304-723-30)", "package_ndc": "63304-723-30", "marketing_start_date": "20201209"}, {"sample": false, "description": "90 TABLET, EXTENDED RELEASE in 1 BOTTLE (63304-723-90)", "package_ndc": "63304-723-90", "marketing_start_date": "20201209"}], "brand_name": "Bupropion hydrochloride", "product_id": "63304-723_45fe751e-5918-745c-e063-6394a90a5c56", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "63304-723", "generic_name": "Bupropion hydrochloride", "labeler_name": "Sun Pharmaceutical Industries, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Bupropion hydrochloride", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "150 mg/1"}], "application_number": "ANDA200216", "marketing_category": "ANDA", "marketing_start_date": "20201209", "listing_expiration_date": "20261231"}